Remternetug (LY3372993) is a monoclonal antibody that targets pyroglutamylated amyloid beta fibrils (N3pG-Abeta). Remternetug specifically binds to N3pG-Abeta, thereby clearing amyloid plaques in the brain and reducing amyloid burden. Remternetug can be used in research related to Alzheimers disease[1][2].
Molecular Weight:
(144.916 kDa)
Purity:
99.00
CAS Number:
[2571940-41-3]
Target:
Amyloid-beta
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted